This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their meta-analysis, Dr Safdar and colleagues¹ concluded that antibiotic exposure during Escherichia coli O157:H7 colitis was not associated with an increased risk of hemolytic uremic syndrome (HUS). Because the included studies were very heterogeneous, however, conclusions based on a single risk estimate may be misleading.

In Figure 1 of the article, 2 of 9 studies reported significantly increased odds ratios (ORs); 6 studies showed no association; and 1 study, which treated patients with fosfomycin, showed a decreased risk of HUS. Safdar et al treated the 2 studies with increased ORs as statistical outliers and averaged these effects against the much larger studies.

Part of this heterogeneity may be related to underlying biological mechanisms. Different strains of E coli O157:H7 respond differently in their production of Shiga-toxin with exposure to subinhibitory concentrations of antibiotics; some strains increase Shiga-toxin production while others do not.² This is believed to . . . [Full Text of this Article]

RELATED ARTICLES

Risk of Hemolytic Uremic Syndrome After Antibiotic Treatment of Escherichia coli O157:H7 Enteritis: A Meta-analysis
Nasia Safdar, Adnan Said, Ronald E. Gangnon, and Dennis G. Maki
JAMA. 2002;288(8):996-1001.
ABSTRACT | FULL TEXT  

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Stephen Hulley, Deborah Grady, Trudy Bush, Curt Furberg, David Herrington, Betty Riggs, Eric Vittinghoff, and for the Heart and Estrogen/progestin Replacement Study Research Group
JAMA. 1998;280(7):605-613.
ABSTRACT | FULL TEXT